Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives

Angewandte Chemie
Katrin KnopUlrich S Schubert

Abstract

Poly(ethylene glycol) (PEG) is the most used polymer and also the gold standard for stealth polymers in the emerging field of polymer-based drug delivery. The properties that account for the overwhelming use of PEG in biomedical applications are outlined in this Review. The first approved PEGylated products have already been on the market for 20 years. A vast amount of clinical experience has since been gained with this polymer--not only benefits, but possible side effects and complications have also been found. The areas that might need consideration and more intensive and careful examination can be divided into the following categories: hypersensitivity, unexpected changes in pharmacokinetic behavior, toxic side products, and an antagonism arising from the easy degradation of the polymer under mechanical stress as a result of its ether structure and its non-biodegradability, as well as the resulting possible accumulation in the body. These possible side effects will be discussed in this Review and alternative polymers will be evaluated.

References

Sep 30, 1976·The New England Journal of Medicine·G Gregoriadis
Sep 23, 1976·The New England Journal of Medicine·G Gregoriadis
May 1, 1992·Gastrointestinal Endoscopy·E BrulletJ Sola
May 1, 1991·Gastrointestinal Endoscopy·E Schuman, P E Balsam
Nov 2, 1990·Biochimica Et Biophysica Acta·G Blume, G Cevc
Aug 1, 1987·Pharmaceutical Research·Y TakakuraH Sezaki
Jan 1, 1989·Biochemical Pharmacology·D A HeroldD E Bruns
Jul 1, 1987·Journal of Biomedical Materials Research·M S Payne, T A Horbett
Oct 1, 1966·Angewandte Chemie·W SeeligerH Hellmann
Nov 1, 1971·Toxicology and Applied Pharmacology·W R Michael, R H Coots
Jan 1, 1983·International Archives of Allergy and Applied Immunology·A W Richter, E Akerblom
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L W SeymourR Duncan
Oct 12, 1994·Biochimica Et Biophysica Acta·V P TorchilinA M Milstein
Mar 18, 1994·Science·R GrefR Langer
Sep 1, 1995·Journal of Pharmaceutical Sciences·V P TorchilinF M Veronese
Feb 1, 1996·Journal of Pharmaceutical Sciences·S ZalipskyT M Allen
Aug 1, 1996·Gastrointestinal Endoscopy·N Stollman, H D Manten
Jan 10, 1998·American Journal of Hematology·P DunnM J Chang
Feb 17, 1998·Journal of Microencapsulation·V P Torchilin
Jul 21, 1998·Bioconjugate Chemistry·C Monfardini, F M Veronese
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H MaedaK Hori
Aug 10, 2000·Pharmaceutical Development and Technology·M MoneghiniL Magarotto
Oct 31, 2000·Biomaterials·J C Middleton, A J Tipton
Dec 8, 2000·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·J Janatova
Jan 6, 2001·Journal of Drug Targeting·A H BrouwersF H Corstens
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J G ShiahJ Kopecek
Mar 17, 2001·Advanced Drug Delivery Reviews·K A JanesM J Alonso
Mar 22, 2001·Advanced Drug Delivery Reviews·J Kost, R Langer
Apr 6, 2001·International Journal of Toxicology·D E Johnson

❮ Previous
Next ❯

Citations

Sep 15, 2012·Biomedical Microdevices·Sunghoon ChoSukho Park
Dec 29, 2013·Analytica Chimica Acta·Anna C CreceliusUlrich S Schubert
Jan 15, 2014·Journal of Chromatography. a·Jianlou NiuZhifeng Huang
Jul 23, 2013·Colloids and Surfaces. B, Biointerfaces·Steven S S WangJeng-Shiung Jan
Feb 18, 2014·Colloids and Surfaces. B, Biointerfaces·Özge ErdemliAyşen Tezcaner
Feb 23, 2013·ACS Applied Materials & Interfaces·Elena HeisterAlan B Dalton
Sep 17, 2011·Accounts of Chemical Research·Jesse V Jokerst, Sanjiv S Gambhir
May 10, 2012·Accounts of Chemical Research·Lígia C Gomes-da-SilvaJoão N Moreira
Jul 13, 2013·Biomacromolecules·Brooke L FarrugiaTim R Dargaville
Jun 19, 2012·Chemistry of Materials : a Publication of the American Chemical Society·Nate Larson, Hamidreza Ghandehari
Aug 2, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Cancan LiX X Zhu
Dec 25, 2012·Molecular Pharmaceutics·Nathalie M PinkertonRobert K Prud'homme
Oct 22, 2011·Nature Reviews. Drug Discovery·Mark E LobattoWillem J M Mulder
Aug 19, 2010·Chemical Communications : Chem Comm·Daniel CrespyAlexander Schiller
Mar 2, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·Thomas D SchladtWolfgang Tremel
Feb 22, 2011·Chemical Communications : Chem Comm·Baoxiang GaoXinwu Ba
Mar 6, 2012·Chemical Society Reviews·Nazila KamalyOmid C Farokhzad
Apr 7, 2012·Nanoscale·De-Hao TsaiVincent A Hackley
Oct 15, 2013·Nanoscale·Christian SchmidtkeHorst Weller
Jun 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Che-Ming J HuLiangfang Zhang
Aug 1, 2012·Proceedings of the National Academy of Sciences of the United States of America·Erika I GeihePaul A Wender
Jun 12, 2013·Protein Engineering, Design & Selection : PEDS·Martin SchlapschyArne Skerra
Jan 20, 2012·Rheumatology·Rachel A FarrellPaul I Creeke
Jul 24, 2012·Journal of the International Society of Sports Nutrition·Robert CooperAlfonso Jimenez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.